Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini

Antimicrob Agents Chemother. 2007 Mar;51(3):1096-8. doi: 10.1128/AAC.01366-06. Epub 2006 Dec 28.

Abstract

We examined the in vivo activity of tribendimidine against selected trematodes. A single 150-mg/kg dose of tribendimidine achieved a 99.1% reduction of Clonorchis sinensis in rats. A 400-mg/kg dose of tribendimidine reduced Opisthorchis viverrini in hamsters by 95.7%. High doses of tribendimidine showed no activity against Schistosoma mansoni and Fasciola hepatica.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthelmintics / therapeutic use*
  • Clonorchiasis / drug therapy*
  • Clonorchiasis / parasitology
  • Clonorchis sinensis / drug effects
  • Cricetinae
  • Fasciola hepatica / drug effects*
  • Fascioliasis / drug therapy*
  • Fascioliasis / parasitology
  • Female
  • Male
  • Mesocricetus
  • Mice
  • Opisthorchis / drug effects*
  • Opisthorchis / parasitology
  • Phenylenediamines / therapeutic use*
  • Rats
  • Rats, Wistar
  • Schistosoma mansoni / drug effects*
  • Schistosomiasis mansoni / drug therapy*
  • Schistosomiasis mansoni / parasitology*

Substances

  • Anthelmintics
  • Phenylenediamines
  • tribendimidine